VC firms
Edit
Aglaia Biomedical Ventures
https://aglaia-biomedical.com/Last activity: 26.06.2018
Probably Closed
Overview
Investment Type
Venture Capital
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 6, 2017 | We’re not done with chemotherapy, so why not improve it? | Based in the Netherlands, Modra Pharmaceuticals is taking aim at a group of chemotherapy agents known as taxanes, which include paclitaxel (Taxol) and docetaxel (Taxotere). Despite their widespread use, taxanes are poorly soluble — a charac... |
| Jun 2, 2017 | Inthera Bioscience Raises CHF 10.5 Million in Series A Financing Round | |
| Dec 14, 2015 | Inthera Bioscience raises EUR 3.4 million in seed financing round | |
| Sep 18, 2014 | Aglaia Launched €65M VC Fund focused on Startups Curing Cancer | Aglaia, a venture capital firm based in Bilthoven, the Netherlands, launched a €65m fund. Aglaia Oncology Fund II, which is backed by high-net-worth families, institutional investors, including the European Investment Fund (EIF), will inves... |
| We’re not done with chemotherapy, so why not improve it? | It’s hard to get excited about a modified chemotherapy drug in an era of personalized medicine, checkpoint inhibitors, and CAR-T immunotherapies. But it would be a mistake to not embrace a potential advance in this field, given the degree t... |
Reviews 0
FAQ about Aglaia Biomedical Ventures
What has the press written about Aglaia Biomedical Ventures?
Parsers VC has collected 6 articles mentioning Aglaia Biomedical Ventures, among them “We’re not done with chemotherapy, so why not improve it?” (Jul 6, 2017) and “Inthera Bioscience Raises CHF 10.5 Million in Series A Financing Round” (Jun 2, 2017).
Is Aglaia Biomedical Ventures still active?
Aglaia Biomedical Ventures is probably closed: its latest activity on Parsers VC dates from Jun 26, 2018.